CẬP NHẬT TIẾP CẬN NHANH VÀ XỬ LÝ SỚM SỐC PHẢN VỆ DO THUỐC CẢN QUANG

Bui Van Lenh1, Le Tuan Linh1, Hoang Bui Hai
1 University Hospital of Medicine

Main Article Content

Abstract

SUMMARY


Anaphylaxis to radiocontrast substance present with pruritus, urticaria, angioedema, laryngospasm, bronchospasm, hypotension, and/or loss of consciousness. Most are mild, but a small number are life-threatening. These reactions typically develop within five minutes to one hour after administration. Higher osmolality substances cause more anaphylaxis compared to lower osmolality agents or iso-osmolal agents. Most hospital now administer
nonionic lower osmolality agents routinely for its intravascular procedures.
The diagnosis of anaphylaxis is based upon the recognition of characteristic signs and symptoms. Laboratory testing is not required.
Management: The infusion of radiocontrast substance should be stopped immediately as soon as a hypersensitivity reaction is recognized. Subsequent treatment depends upon the severity of the reaction. The treatment of anaphylaxis includes adrenalin as soon as possible by intramuscular injection then intravenously if the symptoms are resistant, intravenous fluids, oxygen, diphenhydramin (antihistamin H1) and corticosteroid intravenously, intubation may be required. Particularly, patients with cardiac arrest should be managed according to advanced cardiac life support guidelines.

Article Details

References

TÀI LIỆU THAM KHẢO
1. Timothy J.Bedient and Marin H. Kollef (2012), 1. Anaphylactic Shock, The Wasington Manual of Critical Care, p23-26.
2. Oswalt ML, Kemp SF. Anaphylaxis: office 2. management and prevention. Immunol Allergy Clin North Am 2007; 27:177.
3. Sampson HA, Muñoz-Furlong A, Campbll 3. RL, et al. Second symposium on the definition and management of anaphylaxis: summary report--Second National Institute of Allergy and Infectious Disease/Food Allergy and Anaphylaxis Network symposium. J Allergy Clin Immunol 2006; 117:391.
4. Christiansen C. X-ray contrast media--an 4. overview. Toxicology 2005; 209:185.
5. Brockow K, Christiansen C, Kanny G, et al. 5. Management of hypersensitivity reactions to iodinated contrast media. Allergy 2005; 60:150.
6. Katayama H, Yamaguchi K, Kozuka T, et al. 6. Adverse reactions to ionic and nonionic contrast media. A report from the Japanese Committee on the Safety of Contrast Media. Radiology 1990; 175:621.
7. F Estelle R Simons, Carlos A Camargo, Bruce S 7. Bochner, Anaphylaxis: Rapid recognition and treatment. Uptodate last updated: May 14, 2012.